-
I-Mab Announces Execution of Senior Management Team Share Purchase Plan
prnasia
January 17, 2022
I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the senior management team of the Company...
-
Bionomics Announces Plans to Conduct U.S. Initial Public Offering
prnasia
August 03, 2021
Bionomics Limited, (Bionomics) a global, clinical stage biopharmaceutical company, is pleased to announce that it plans to conduct a registered initial public offering of American Depositary Shares (ADSs) in the United States and a concurrent listing ...
-
Inventiva announces the implementation of an At-The-Market program in the United States
firstwordpharma
August 03, 2021
Inventiva today announced the implementation of an At-The-Market ("ATM") program allowing the Company to issue and sell, including with unsolicited investors who have expressed an interest, ordinary shares in the form of American Depositary Shares ("ADS")
-
I-Mab Announces Authorization of a Renewed Stock Repurchase Program by the Company up to US$40 Million
prnasia
July 30, 2021
I-Mab, a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, announced that its Board of Directors has authorized a new stock repurchase program. With the Board's authorization ...
-
Gracell Biotechnologies Announces Pricing of Initial Public Offering
prnasia
January 08, 2021
Gracell Biotechnologies Inc. announced the pricing of its initial public offering of 11,000,000 American Depositary Shares ("ADSs"), each representing five ordinary shares, at a public offering price of US$19.00 per ADS.
-
TV Pharma Ads Now Required to Include Pricing
americanpharmaceuticalreview
May 13, 2019
Health and Human Services Secretary Alex Azar has announced the Trump administration has finalized regulations that will require pharmaceutical companies to disclose the list price of medications costing more than $35 for a month’s supply.
-
Prices Will Soon Be Included in TV Drug Ads
drugs
May 09, 2019
Prices Will Soon Be Included in TV Drug Ads.
-
Why Amarin's Latest News Caused Shares to Crash 13% Today
fool
November 28, 2018
After the company announced a $200 million secondary offering of its American Depository Shares (ADS), Amarin Corporation plc (NASDAQ:AMRN) shares tumbled 13% on Tuesday......